MAPT and amyloidosis: Given that the proteins measured in this study included those that were previously identified as markers of other AD related measures [including cognitive decline, CSF Tau/Aβ and brain atrophy (Hye et al., 2014; Sattlecker et al., 2014)] they may not necessarily be specific to the load of fibrillised amyloid deposits in brain.